The Cancer and Blood Diseases Institute at Cincinnati Children’s is a national leader in caring for children and young adults with cancer. Here, our patients, parents, physicians and researchers all work together to take on the toughest, most complex cancer cases.

And that's why we’re a top-ranked program. 

We’re ranked No. 6 in the nation by U.S. News & World Report, and we’re accredited with commendation from the American College of Surgeons Commission on Cancer. We don’t stop there. Our pediatric cancer rehabilitation program is the first in the world to be accredited by the Commission on Accreditation of Rehabilitation Facilities (CARF).

The director of the Division of Oncology is John Perentesis, MD, a nationally recognized expert in the development of anticancer drugs for children and young adults. His leadership roles have included the National Cancer Institute's Investigational Drug Steering Committee, the Neurofibromatosis Consortium Drug Development and Executive Committees, the Myeloid Leukemia Relapse Committee and the Adolescent / Young Adult Cancer Committee of the Children's Oncology Group. Perentesis and our experienced specialists offer the most advanced therapies for patients who are newly diagnosed, and those seeking innovative treatments for rare, relapsed and recurrent cancers.

Our team of doctors, nurses, social workers and other care team members work relentlessly each and every day to provide early and accurate diagnoses, appropriate medical treatment, family support and patient education. We strive to help patients maintain a “normal” life by helping them keep up in school and providing treatment on an outpatient (rather than inpatient) basis whenever possible.